These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16005462)

  • 1. Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: impact of plaque composition and lipoprotein phenotype.
    Zambon A; Puato M; Faggin E; Bertocco S; Vitturi N; Polentarutti V; Deriu GP; Grego F; Bertipaglia B; Rattazzi M; Vianello D; Deeb SS; Pauletto P
    Atherosclerosis; 2006 Mar; 185(1):121-6. PubMed ID: 16005462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the --514 C-->T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis.
    Faggin E; Zambon A; Puato M; Deeb SS; Bertocco S; Sartore S; Crepaldi G; Pessina AC; Pauletto P
    J Am Coll Cardiol; 2002 Sep; 40(6):1059-66. PubMed ID: 12354428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific cellular features of atheroma associated with development of neointima after carotid endarterectomy: the carotid atherosclerosis and restenosis study.
    Pauletto P; Puato M; Faggin E; Santipolo N; Pagliara V; Zoleo M; Deriu GP; Grego F; Plebani M; Sartore S; Bon GB; Heymes C; Samuel JL; Pessina AC
    Circulation; 2000 Aug; 102(7):771-8. PubMed ID: 10942746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: a flag for non-HDL-C.
    Zambon A; Puato M; Faggin E; Grego F; Rattazzi M; Pauletto P
    Atherosclerosis; 2013 Sep; 230(1):106-9. PubMed ID: 23958261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between well-characterized lipoprotein-related genetic variants and carotid intimal medial thickness and stenosis: The Framingham Heart Study.
    Elosua R; Cupples LA; Fox CS; Polak JF; D'Agostino RA; Wolf PA; O'Donnell CJ; Ordovas JM
    Atherosclerosis; 2006 Nov; 189(1):222-8. PubMed ID: 16430904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteryl ester transfer protein and hepatic lipase gene polymorphisms: effects on hepatic mRNA levels, plasma lipids and carotid atherosclerosis.
    Soyal SM; Sandhofer A; Hahne P; Oberkofler H; Felder T; Iglseder B; Miller K; Krempler F; Patsch JR; Paulweber B; Patsch W
    Atherosclerosis; 2011 Jun; 216(2):374-80. PubMed ID: 21371711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    Beilby JP; Hunt CC; Palmer LJ; Chapman CM; Burley JP; McQuillan BM; Thompson PL; Hung J;
    Stroke; 2003 Apr; 34(4):869-74. PubMed ID: 12637699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systemic review into carotid plaque features as predictors of restenosis after carotid endarterectomy.
    Zhou F; Hua Y; Ji X; Jia L
    J Vasc Surg; 2021 Jun; 73(6):2179-2188.e4. PubMed ID: 33253876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy.
    Zambon A; Deeb SS; Pauletto P; Crepaldi G; Brunzell JD
    Curr Opin Lipidol; 2003 Apr; 14(2):179-89. PubMed ID: 12642787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum high-density lipoprotein cholesterol levels.
    Isaacs A; Aulchenko YS; Hofman A; Sijbrands EJ; Sayed-Tabatabaei FA; Klungel OH; Maitland-van der Zee AH; Stricker BH; Oostra BA; Witteman JC; van Duijn CM
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2680-7. PubMed ID: 17440012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A
    Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.
    Tahvanainen E; Syvanne M; Frick MH; Murtomaki-Repo S; Antikainen M; Kesaniemi YA; Kauma H; Pasternak A; Taskinen MR; Ehnholm C
    J Clin Invest; 1998 Mar; 101(5):956-60. PubMed ID: 9486964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis?
    Shah F; Balan P; Weinberg M; Reddy V; Neems R; Feinstein M; Dainauskas J; Meyer P; Goldin M; Feinstein SB
    Vasc Med; 2007 Nov; 12(4):291-7. PubMed ID: 18048465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment.
    Zambon A; Deeb SS; Brown BG; Hokanson JE; Brunzell JD
    Circulation; 2001 Feb; 103(6):792-8. PubMed ID: 11171785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-borne tissue factor activity predicts major cerebrovascular events in patients undergoing carotid endarterectomy: results from a 1-year follow-up study.
    Krupinski J; Turu MM; Font MA; Catena E; Slevin M; Morchon S; Rubio F; Badimon L; Martínez-González J
    Cerebrovasc Dis; 2008; 25(1-2):32-9. PubMed ID: 18033956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol ester transfer protein (CETP) Taq1B polymorphism influences the effect of a standardized cardiac rehabilitation program on lipid risk markers.
    Ayyobi AF; Hill JS; Molhuizen HO; Lear SA
    Atherosclerosis; 2005 Aug; 181(2):363-9. PubMed ID: 16039291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerotic plaque composition and occurrence of restenosis after carotid endarterectomy.
    Hellings WE; Moll FL; De Vries JP; Ackerstaff RG; Seldenrijk KA; Met R; Velema E; Derksen WJ; De Kleijn DP; Pasterkamp G
    JAMA; 2008 Feb; 299(5):547-54. PubMed ID: 18252885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
    van Acker BA; Botma GJ; Zwinderman AH; Kuivenhoven JA; Dallinga-Thie GM; Sijbrands EJ; Boer JM; Seidell JC; Jukema JW; Kastelein JJ; Jansen H; Verhoeven AJ;
    Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.